Rimexolone
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | |
Clinical data | |
AHFS/Drugs.com | monograph |
MedlinePlus | a606003 |
Pregnancy cat. | C (US) |
Legal status | ? |
Routes | occular |
Identifiers | |
CAS number | 49697-38-3 |
ATC code | H02AB12 S01BA13 |
PubChem | CID 16051942 |
DrugBank | DB00896 |
ChemSpider | 10482044 |
UNII | O7M2E4264D |
KEGG | D05729 |
ChEMBL | CHEMBL1200617 |
Chemical data | |
Formula | C24H34O3 |
Mol. mass | 370.525 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.
References
- ↑ Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.